title: [Autoimmune pancreatitis].
abstract: Autoimmune pancreatitis has been established as a special entity of pancreatitis. It is an enigmatic disease since it is adding an autoimmune etiology to the existing causes of pancreatitis. Morphological hallmarks of the disease are narrowing of the pancreatic duct system and the bile duct by periductal lymphoplasmocytic inflammation. This results in many cases in obstructive jaundice due to a mass-forming lesion in the pancreatic head mimicking pancreatic ductal adenocarcinoma. Therefore, patients will frequently undergo surgery. Histopathologically, the disease can be diagnosed by IgG4-positive plasma cells. Serologically, patients may present with elevated serum IgG and IgG4 levels. Other autoantibodies are also described. Association with other autoimmune manifestations in a wide range of organs is frequent. Autoimmune pancreatitis will respond to steroid treatment, which is of specific importance because pancreatic cancer is one of its clinical differential diagnoses. It is important to positively diagnose autoimmune pancreatitis, especially if the bile ducts are affected, since cholangitis may be or become a prominent problem before or after surgery.
authors.affiliation: II. Medizinische Klinik, Medizinische Fakultät Mannheim der Universität Heidelberg, Universitätsmedizin Mannheim, Mannheim, Deutschland.
authors.forename: A
authors.initials: A
authors.lastname: Schneider
authors.forename: J M
authors.initials: JM
authors.lastname: Löhr
mesh_terms: D001327:Autoimmune Diseases / Q000175:diagnosis* / Q000628:therapy*; D002756:Cholagogues and Choleretics / Q000008:administration & dosage; D006801:Humans; D010195:Pancreatitis / Q000175:diagnosis* / Q000628:therapy*
chemical_list: D002756:Cholagogues and Choleretics